These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1501727

  • 1. Renal transplant recipients and chronic liver disease: statistical evaluation of predisposing factors.
    Aroldi A, Tarantino A, Montagnino G, Paparella M, Cesana B, Rumi MG, Ponticelli C.
    Nephron; 1992; 61(3):290-2. PubMed ID: 1501727
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combined effects of chronic hepatitis virus infections and substance-use habits on chronic liver diseases in Taiwanese aborigines.
    Lin HH, Wang LY, Shaw CK, Cheng ML, Chung WK, Chiang HJ, Lin TY, Chen CJ.
    J Formos Med Assoc; 2002 Dec; 101(12):826-34. PubMed ID: 12632815
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcome of renal transplantation in end-stage renal disease patients with positive pretransplantation hepatitis B surface antigen.
    Patel HV, Kute VB, Vanikar AV, Shah PR, Gumber MR, Jain SH, Engineer DP, Ghelani GH, Trivedi HL.
    Transplant Proc; 2012 Jan; 44(1):72-4. PubMed ID: 22310582
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
    Basic-Jukic N, Kes P, Bubic-Filipi LJ, Puretic Z, Brunetta B, Pasini J.
    Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553
    [Abstract] [Full Text] [Related]

  • 9. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

  • 10. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
    Ahn HJ, Kim MS, Kim YS, Kim SI, Huh KH, Ju MK, Ahn SH, Han KH.
    J Med Virol; 2007 Nov; 79(11):1655-63. PubMed ID: 17854044
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F, Camerin E, Feriani M, Nordio M, Piccoli A, Rossi B, Tessitore N.
    G Ital Nefrol; 2009 Nov; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [Abstract] [Full Text] [Related]

  • 13. Reduction of azathioprine in renal transplant patients with chronic hepatitis.
    Farge D, Parfrey PS, Forbes RD, Dandavino R, Guttmann RD.
    Transplantation; 1986 Jan; 41(1):55-9. PubMed ID: 3510495
    [Abstract] [Full Text] [Related]

  • 14. Blood coagulation, fibrinolytic and inhibitory profiles in renal transplant recipients: comparison of cyclosporine and azathioprine.
    Vaziri ND, Ismail M, Martin DC, Gonzales E.
    Int J Artif Organs; 1992 Jun; 15(6):365-9. PubMed ID: 1639529
    [Abstract] [Full Text] [Related]

  • 15. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A, Le Meur Y, Ecotière L, Abou-Ayache R, Etienne I, Laurent C, Vuiblet V, Colosio C, Bouvier N, Aldigier JC, Rerolle JP, Javaugue V, Gand E, Bridoux F, Essig M, Hurault de Ligny B, Touchard G.
    Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
    [Abstract] [Full Text] [Related]

  • 16. Cataract in renal transplantation recipients with combination ciclosporin treatment.
    Nishimoto K, Sasaki K, Yamamura T, Ishikawa I, Shinoda A.
    Lens Eye Toxic Res; 1992 Jan; 9(3-4):455-67. PubMed ID: 1301797
    [Abstract] [Full Text] [Related]

  • 17. HBsAg as predictor of outcome in renal transplant patients.
    Ridruejo E, Brunet Mdel R, Cusumano A, Diaz C, Michel MD, Jost L, Jost L, Mando OG, Vilches A.
    Medicina (B Aires); 2004 Jan; 64(5):429-32. PubMed ID: 15560544
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Renal transplantation in hepatitis B carriers: comparison of azathioprine- and cyclosporine-treated recipients.
    Lai MK, Huang CC, Chu SH, Chuang CK, Fong MT.
    Clin Transpl; 1989 Jan; ():281-6. PubMed ID: 2487573
    [Abstract] [Full Text] [Related]

  • 20. Liver disease in recipients of long-functioning renal allografts.
    Weir MR, Kirkman RL, Strom TB, Tilney NL.
    Kidney Int; 1985 Nov; 28(5):839-44. PubMed ID: 3910917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.